A recent video from ZipTrader with over 861K subscribers is getting a lot of attention after breaking down why one $21 stock could have massive upside through theA recent video from ZipTrader with over 861K subscribers is getting a lot of attention after breaking down why one $21 stock could have massive upside through the

Here’s Why This $21 Stock Has CRAZY Potential

2026/03/19 04:00
Okuma süresi: 5 dk
Bu içerikle ilgili geri bildirim veya endişeleriniz için lütfen [email protected] üzerinden bizimle iletişime geçin.

A recent video from ZipTrader with over 861K subscribers is getting a lot of attention after breaking down why one $21 stock could have massive upside through the rest of 2026. 

The stock in question is Unusual Machines (UMAC), and the argument is that the fundamentals are getting stronger, the macro environment is turning in its favor, and the growth story is just getting started.

Let’s break it down in plain terms.

Why This Stock Is Getting Attention

On the surface, the numbers are certainly impressive. The firm has seen revenue growth that has more than doubled in the latest quarter, marking seven straight quarters of record revenue. In addition, the firm has seen increased margins, which demonstrates that the firm is not only growing, but it is doing so in a more efficient manner.

Read Also: Silver Price Explosion Incoming: The $150 Target That Changes Everything, But There’s a Catch

But what’s really catching investors’ attention is the pipeline of government contracts. The company has secured multiple deals tied to U.S. military demand, and there’s still a backlog waiting to be fulfilled. That kind of visibility is something many small-cap stocks simply don’t have.

There’s also a political angle here. The company has connections linked to the Trump administration, and with a stronger focus on domestic manufacturing, that relationship is being seen as a potential tailwind rather than just a headline.

What the Company Actually Does

To understand the hype, you need to understand the business model. Unusual Machines isn’t building flashy consumer drones. Instead, it’s focused on the items that go inside them.

For example, think of flight controllers, cameras, motors, and video transmitters, etc., which are basically essential items that go inside drones.

In other words, they are selling “picks and shovels” in a growing industry.

This is important because instead of betting on which drone company wins, they benefit from the entire industry growing. Whether it is military drones or commercial usage, someone needs these parts, and that is where UMAC comes in.

The company also owns brands such as Fat Shark, which is known for its First Person View Goggles, and Rotor Riot, which gives them access to the large drone enthusiast community. So it has both the infrastructure side and a consumer-facing presence.

Read Also: Here’s Where Gold Price Could Go After the FOMC Decision

Their Biggest Advantage

One of the strongest arguments for this stock is its positioning in the U.S. supply chain.

Most drone components globally are manufactured in China. However, U.S. military rules restrict the use of foreign components, especially from China, due to security concerns. This creates a gap in the market.

UMAC is one of the few companies producing these components domestically at scale. It makes it very relevant, especially as the US continues to advocate for more ‘Made in America’ defense production.

The company has also grown, as it has increased its production capacity considerably in a short time. It would seem that the company is expecting an increased demand rather than just reacting to it.

The Bigger Picture: Why 2026 Could Be Huge

The general environment is also favorable for the company. The tensions between nations, especially between the US and Iran, have put drones at the center of modern warfare. This has led many nations to invest heavily in drone technology for both offense and defense strategies.

This has led to an increase in demand for drone hardware. And since UMAC supplies those components, it’s directly positioned to benefit from this trend.

On top of that, government policies are increasingly supporting domestic production. Executive orders and defense priorities are aligning with what UMAC already does, turning it from a small-cap story into a potential policy-backed growth play.

But There Are Risks Too

Even with all the bullish arguments, this isn’t a risk-free play. For one, the stock behaves a bit like a meme stock. It has a relatively small float and strong retail interest, which means it can swing sharply in either direction based on news or sentiment.

There’s also political risk. While current connections may be helping, any shift in the political landscape could change that dynamic quickly.

Execution is another factor. The company is scaling rapidly and handling large contracts at the same time. That kind of growth can come with operational challenges, and any misstep could impact performance.

Read Also: Here’s the Hyperliquid (HYPE) Price if S&P 500 Perps Trigger Institutional Inflows

Moreover, the story around Unusual Machines is gaining traction for a reason. The company sits at the intersection of a booming industry, supportive government policy, and improving financial performance.

At around $21, the stock has already made a move, but according to the thesis presented by ZipTrader, the setup today may actually be stronger than it was when the stock was cheaper.

Still, as with any small cap growth stock, it is not without its volatility and uncertainties. The opportunity is certainly here, as is the risk.

As always, the key is to see past the hype, understand the business, and determine if the long-term story makes sense for you.

Subscribe to our YouTube channel for daily crypto updates, market insights, and expert analysis.

The post Here’s Why This $21 Stock Has CRAZY Potential appeared first on CaptainAltcoin.

Piyasa Fırsatı
League of Traders Logosu
League of Traders Fiyatı(LOT)
$0.007802
$0.007802$0.007802
+2.09%
USD
League of Traders (LOT) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen [email protected] ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

The post Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference appeared on BitcoinEthereumNews.com. The suitcoiners are in town.  From a low-key, circular podium in the middle of a lavish New York City event hall, Strategy executive chairman Michael Saylor took the mic and opened the Bitcoin Treasuries Unconference event. He joked awkwardly about the orange ties, dresses, caps and other merch to the (mostly male) audience of who’s-who in the bitcoin treasury company world.  Once he got onto the regular beat, it was much of the same: calm and relaxed, speaking freely and with confidence, his keynote was heavy on the metaphors and larger historical stories. Treasury companies are like Rockefeller’s Standard Oil in its early years, Michael Saylor said: We’ve just discovered crude oil and now we’re making sense of the myriad ways in which we can use it — the automobile revolution and jet fuel is still well ahead of us.  Established, trillion-dollar companies not using AI because of “security concerns” make them slow and stupid — just like companies and individuals rejecting digital assets now make them poor and weak.  “I’d like to think that we understood our business five years ago; we didn’t.”  We went from a defensive investment into bitcoin, Saylor said, to opportunistic, to strategic, and finally transformational; “only then did we realize that we were different.” Michael Saylor: You Come Into My Financial History House?! Jokes aside, Michael Saylor is very welcome to the warm waters of our financial past. He acquitted himself honorably by invoking the British Consol — though mispronouncing it, and misdating it to the 1780s; Pelham’s consolidation of debts happened in the 1750s and perpetual government debt existed well before then — and comparing it to the gold standard and the future of bitcoin. He’s right that Strategy’s STRC product in many ways imitates the consols; irredeemable, perpetual debt, issued at par, with…
Paylaş
BitcoinEthereumNews2025/09/18 02:12
Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

The post Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent? appeared on BitcoinEthereumNews.com. In brief The White House registered aliens.gov
Paylaş
BitcoinEthereumNews2026/03/19 05:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Paylaş
BitcoinEthereumNews2025/09/18 05:26